Maravai Lifesciences Holdings (MRVI) Return on Assets (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Return on Assets of 0.0% in Q1 2026, up 12.82% quarter-over-quarter from 0.0% in Q4 2025, and little changed on a YoY basis from 0.0% in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Return on Assets (2021 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Return on Assets history runs 6 years deep, the most recent figure standing at 0.0% for Q1 2026.
- In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
- Return on Assets was 0.0% for Q1 2026 at Maravai Lifesciences Holdings, up from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2022 to a low of 0.0% in Q2 2025.
- Historically, Return on Assets has averaged 0.0% across 5 years, with a median of 0.0% in 2024.
- Biggest YoY gain for Return on Assets was 0 bps in 2022; the steepest drop was 0 bps in 2022.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then plunged by 134 bps to 0.0% in 2023, then slumped by 208 bps to 0.0% in 2024, then dropped by 25 bps to 0.0% in 2025, then gained by 13 bps to 0.0% in 2026.
- The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -0.01% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.01% |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |